Mutant P53 in the formation and progression of the tumor microenvironment: friend or foe

ER Asl, D Rostamzadeh, PHG Duijf, S Mafi, B Mansoori… - Life sciences, 2023 - Elsevier
TP53 is the most frequently mutated gene in human cancer. It encodes the tumor suppressor
protein p53, which suppresses tumorigenesis by acting as a critical transcription factor that …

Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer

X Zhang, X Wang, L Hou, Z Xu, Y Liu… - Frontiers in …, 2023 - frontiersin.org
Lung cancer is one of the common malignant cancers worldwide. Immune checkpoint
inhibitor (ICI) therapy has improved survival of lung cancer patients. However, ICI therapy …

The effect of gD-derived peptides on T cell immune response mediated by BTLA-HVEM protein complex in melanoma patients

K Wojciechowicz, K Kuncewicz, J Rutkowski… - Frontiers in …, 2024 - frontiersin.org
Introduction The effector function of T cells is regulated via immune checkpoints, activating
or inhibiting the immune response. The BTLA-HVEM complex, the inhibitory immune …

Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy

K Huang, X Huang, C Zeng, S Wang, Y Zhan, Q Cai… - Cancer Imaging, 2024 - Springer
Background Our previous study suggests that tumor CD8+ T cells and macrophages
(defined as CD68+ cells) infiltration underwent dynamic and heterogeneous changes during …

Impact of Chemotherapeutic Agents on PD-L1, CTLA-4, and VISTA Gene Expression in Cervical Cancer Cell Lines: An In Vitro Study

H Nasiri, M Ahmadpour Youshanlui… - Indian Journal of …, 2024 - Springer
Purpose The study aims to understand how docetaxel and doxorubicin, two commonly used
chemotherapeutic drugs, influence the expression of PD-L1, CTLA-4, and VISTA in cervical …

[PDF][PDF] Author Queries Form

A Hsu, CC Woo, KHB Tan, A Chinnathambi… - researchgate.net
Q3 The citation and surnames of all of the authors have been highlighted. Check that they
are correct and consistent with your previous publications, and correct them if needed …